Neogen (NEOG) Other Non-Current Liabilities (2016 - 2026)
Neogen's (NEOG) quarterly Other Non-Current Liabilities came in at $43.5 million in Q1 2026, up 0.86% year-on-year from $43.1 million in Q1 2025, and up 4.71% quarter-over-quarter from $41.5 million in Q4 2025.
Neogen (NEOG) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
Neogen's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $43.5 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 0.86% year-over-year to $43.5 million in Q1 2026; TTM through Feb 2026 was $43.5 million, a 0.86% increase from a year earlier, with the FY2025 full-year figure at $42.9 million, up 21.67% from the prior year.
- Other Non-Current Liabilities rose to $43.5 million in Q1 2026 per NEOG's latest filing, from $41.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $43.5 million in Q3 2025 and bottomed at $10.7 million in Q3 2022.
- The 5-year median for Other Non-Current Liabilities is $36.3 million (2023), against an average of $32.9 million.
- Biggest YoY gain for Other Non-Current Liabilities was 252.87% in 2022; the steepest drop was 9.74% in 2022.
- Year by year, Other Non-Current Liabilities stood at $16.2 million in 2022, then surged by 124.08% to $36.3 million in 2023, then grew by 14.43% to $41.6 million in 2024, then retreated by 0.03% to $41.5 million in 2025, then climbed by 4.71% to $43.5 million in 2026.
- Per Business Quant, the three latest NEOG Other Non-Current Liabilities figures stand at $43.5 million (Q1 2026), $41.5 million (Q4 2025), and $43.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 43.50 Mn |
| Nov 30, 2025 | 41.54 Mn |
| Aug 31, 2025 | 43.52 Mn |
| May 31, 2025 | 42.90 Mn |
| Feb 28, 2025 | 43.13 Mn |
| Nov 30, 2024 | 41.56 Mn |
| Aug 31, 2024 | 38.59 Mn |
| May 31, 2024 | 35.26 Mn |
| Feb 29, 2024 | 36.97 Mn |
| Nov 30, 2023 | 36.32 Mn |
| Aug 31, 2023 | 35.83 Mn |
| May 31, 2023 | 35.88 Mn |
| Feb 28, 2023 | 28.72 Mn |
| Nov 30, 2022 | 16.21 Mn |
| Aug 31, 2022 | 10.65 Mn |
| May 31, 2022 | 10.70 Mn |
| Feb 28, 2022 | 18.76 Mn |
| Nov 30, 2021 | 17.96 Mn |
| Aug 31, 2021 | 4.15 Mn |
| May 31, 2021 | 4.30 Mn |